Eugenol (EU) – PEG adduct was synthesized to improve the chemical and physical properties of eugenol. The phenolic group was covalently bound to the carboxyl group of PEG and the release kinetics were studied in vitro in buffer solution at pH 7.4, in simulated gastric fluid and in mouse plasma. Studies in vitro on the release of the parent drug from the prodrug in various media indicate that the adduct may be sufficiently stable to pass intact into the gastrointestinal tract and release EU into the circulation. The antioxidant activity of PEG-EU adduct was also evaluated. Scavenging activity was absent in the original PEG-EU adduct but gradually increased on the basis of drug delivery.
KannisseryP, AnsariSH, JavedA. (2010) Eugenol: A natural compound with versatile pharmacological actions. Natural Product Communications, 5, 1999–2006.
2.
FujisamaS, AtsumiT, KadomaY, SakagamiH. (2002) Antioxidant and prooxidant action of eugenol-related compounds and their cytotoxicity. Toxicology, 177, 39–54.
3.
YogalakshmiB, ViswanathanP, AnuradhaCV. (2010) Investigation of anti-oxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology, 268, 204–212.
4.
MitragotriS, BurkePA, LangerR. (2014) Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nature reviews. Drug Discovery, 13, 655–672.
5.
ZacchignaM, CateniF, VoinovichD, GrassiM, DrioliS, BonoraGM. (2009) New multidrug (dexamethasone and theophylline) PEG-conjugate: synthesis, in vitro release studies and intestinal permeability. Journal of Drug Delivery Science and Technology, 19, 177–184.
6.
ZacchignaM, CateniF, DrioliS, ProcidaG, AltierT. (2015) A new bi-functional derivative of polyethylene glycol as molecular carrier for eugenol and ibuprofen. Journal of Pharmaceutic & Drug Development, 2, 101–108.
7.
GargL, GuptaB, PrakashR, SinghS. (2010) Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and 1H-NMR. Chemical and Pharmaceutical Bulletin, 58, 1313–1319.
8.
JungBO, ChungSJ, LeeSB. (2006) Preparation and characterization of eugenol-grafted chitosan hydrogels and their antioxidant activities. Journal of Applied Polymer Science, 99, 3500–3506.
9.
HyangN, Moon-MooK. (2013) Eugenol with antioxidant activity inhibits MMP-9 related to metastasis in human fibrosarcoma cells. Food and Chemical Toxicology, 55, 106–112.
10.
GreenwaldRB. (2001) PEG drugs: an overview. Journal of Controlled Release, 74, 159–171.
11.
ZalipskyS. (1995) Functionalized poly(ethylene glycols) for preparation of biologically relevant conjugates. Bioconjugate Chemistry, 6, 150–165.
12.
BloisMS. (1958) Antioxidant determination by the use of a stable free radical. Nature, 29, 1199–1200.
13.
ChoiCW, KimSC, HwangSS, ChoiBK, AhnHJ, LeeMY, ParkSH, KimSK. (2002) Antioxidant activity and free radical scavenging capacity between Korean medicinal plants and flavonoids by assay-guided comparison. Plant Science, 163, 1161–1168.
14.
Brand-WilliamsW, CuvelierME, BersetC. (1995) Use of a free radical method to evaluate antioxidant activity. Lebensmittel-Wissenschaft und-Technologie, 28, 25–30.
15.
ZalipskyS, GilonC, ZilkhaA. (1983) Attachment of drugs to polyethylene glycols. European Polymer Journal, 19, 1177–1183.
